PL379448A1 - Sposób wytwarzania preparatu zawierającego substancję aktywną w mikrodawce - Google Patents

Sposób wytwarzania preparatu zawierającego substancję aktywną w mikrodawce

Info

Publication number
PL379448A1
PL379448A1 PL379448A PL37944804A PL379448A1 PL 379448 A1 PL379448 A1 PL 379448A1 PL 379448 A PL379448 A PL 379448A PL 37944804 A PL37944804 A PL 37944804A PL 379448 A1 PL379448 A1 PL 379448A1
Authority
PL
Poland
Prior art keywords
preparing
formulation containing
active principle
microdosed
microdosed active
Prior art date
Application number
PL379448A
Other languages
English (en)
Other versions
PL213809B1 (pl
Inventor
Yves Cuillery
Denis Chambinaud
Original Assignee
Galderma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma S.A. filed Critical Galderma S.A.
Publication of PL379448A1 publication Critical patent/PL379448A1/pl
Publication of PL213809B1 publication Critical patent/PL213809B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL379448A 2003-05-12 2004-05-07 Sposób wytwarzania zasadniczo homogenicznej formulacji jako masci w mikrodawce PL213809B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0305684A FR2854802B1 (fr) 2003-05-12 2003-05-12 Procede de preparation d'une formulation contenant un principe actif microdose

Publications (2)

Publication Number Publication Date
PL379448A1 true PL379448A1 (pl) 2006-09-18
PL213809B1 PL213809B1 (pl) 2013-05-31

Family

ID=33306296

Family Applications (1)

Application Number Title Priority Date Filing Date
PL379448A PL213809B1 (pl) 2003-05-12 2004-05-07 Sposób wytwarzania zasadniczo homogenicznej formulacji jako masci w mikrodawce

Country Status (16)

Country Link
US (2) US20060115501A1 (pl)
EP (1) EP1624856B1 (pl)
JP (1) JP4865560B2 (pl)
KR (1) KR101125503B1 (pl)
CN (1) CN100411608C (pl)
AR (1) AR044289A1 (pl)
AU (1) AU2004237995B2 (pl)
BR (1) BRPI0409051A (pl)
CA (1) CA2524228A1 (pl)
ES (1) ES2533542T3 (pl)
FR (1) FR2854802B1 (pl)
MX (1) MXPA05011836A (pl)
PL (1) PL213809B1 (pl)
RU (1) RU2349303C2 (pl)
WO (1) WO2004100924A2 (pl)
ZA (1) ZA200508282B (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116531315B (zh) * 2023-03-22 2024-02-13 江苏知原药业股份有限公司 一种卡泊三醇软膏及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56140915A (en) * 1980-04-07 1981-11-04 Yamanouchi Pharmaceut Co Ltd Pharmaceutical preparation for solid drug
AT370721B (de) * 1981-02-24 1983-04-25 Ciba Geigy Ag Verfahren zur herstellung von neuen salzen der 2- (2,6-dichloranilino)-phenylessigsaeure, der
FR2515035A1 (fr) * 1981-10-26 1983-04-29 Rhone Poulenc Sante Nouvelle forme galenique solide pour administration par voie orale et son procede de fabrication
US4610978A (en) * 1983-03-22 1986-09-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same
CN1014867B (zh) * 1987-07-29 1991-11-27 中山大学 分层包衣的微胶囊工艺
JP3137821B2 (ja) * 1994-01-07 2001-02-26 帝人株式会社 安定性の向上した乾癬治療用製剤
JP3506474B2 (ja) * 1994-01-07 2004-03-15 帝人株式会社 安定性の向上した乾癬治療剤
AU2588297A (en) * 1996-04-04 1997-10-29 Ortho Pharmaceutical Corporation Liposome-based topical vitamin d formulation
JP4729149B2 (ja) * 1997-06-25 2011-07-20 帝國製薬株式会社 安定なアスピリン軟膏製剤
US6274169B1 (en) * 1999-08-02 2001-08-14 Abbott Laboratories Low oxygen content compostions of 1α, 25-dihydroxycholecalciferol
WO2002034235A1 (en) * 2000-10-27 2002-05-02 Leo Pharma A/S Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
JP2002321779A (ja) * 2001-04-20 2002-11-05 Daizo:Kk 薬剤の微量拡散方法および微量拡散装置

Also Published As

Publication number Publication date
ES2533542T3 (es) 2015-04-10
ZA200508282B (en) 2006-09-27
CN100411608C (zh) 2008-08-20
FR2854802B1 (fr) 2005-06-24
AU2004237995B2 (en) 2010-11-04
AU2004237995A1 (en) 2004-11-25
JP4865560B2 (ja) 2012-02-01
KR101125503B1 (ko) 2012-03-21
US20070249570A1 (en) 2007-10-25
BRPI0409051A (pt) 2006-03-28
MXPA05011836A (es) 2006-01-26
PL213809B1 (pl) 2013-05-31
FR2854802A1 (fr) 2004-11-19
WO2004100924A2 (fr) 2004-11-25
WO2004100924A3 (fr) 2005-09-15
AR044289A1 (es) 2005-09-07
CN1787807A (zh) 2006-06-14
CA2524228A1 (fr) 2004-11-25
JP2006528674A (ja) 2006-12-21
US20060115501A1 (en) 2006-06-01
RU2005138504A (ru) 2006-07-27
RU2349303C2 (ru) 2009-03-20
KR20060011992A (ko) 2006-02-06
EP1624856A2 (fr) 2006-02-15
HK1091120A1 (zh) 2007-01-12
US7749986B2 (en) 2010-07-06
EP1624856B1 (fr) 2015-01-14

Similar Documents

Publication Publication Date Title
EP1471955A4 (en) AEROSOL GENERATOR FOR A MEDICINAL FORMULATION
IL229510A0 (en) A dosage form containing pantoprazole as an active ingredient
IL174392A0 (en) Stable lansoprazole formulation
SI1608362T1 (sl) Stabiliziran farmacevtski izdelek z amorfno aktivno učinkovino
PL376465A1 (pl) Kompozycja zawierająca mieszaninę składników czynnych oraz sposób jej otrzymywania
PL370452A1 (pl) Preparat w postaci stałego roztworu słabo rozpuszczalnej w wodzie substancji aktywnej
AU2003276054A1 (en) Method for the production of powdered active substance formulations by means of compressible fluids
EP1590144A4 (en) PROCESS FOR THE PREPARATION OF BIOLOGICALLY ACTIVE FORMULATIONS
IL164280A0 (en) Low foaming formulation of glyphosate
PL2083007T3 (pl) Sole tiotropium, sposoby ich wytwarzania oraz zawierające je kompozycje farmaceutyczne
GB0307450D0 (en) Method for interfacing storage devices
GB2412338B (en) Surface preparation of an implant
EP1478396A4 (en) PROCESS FOR PREPARING A PHARMACEUTICAL COMPOSITION
AU2003224467A1 (en) Process for the preparing of hardcapsule formulation containing lansoprazole
HRP20040889A2 (en) Hfa-suspension formulations containing an anticholinergic
ZA200508282B (en) Method of preparing a formulation containing a microdosed active principle
GB0306088D0 (en) Process for the preparation of a cosmetic active
GB0314531D0 (en) Process for the preparation of a cosmetic active
IL176356A0 (en) Effervescent preparation of a basic medical substance
EP1669087A4 (en) PREPARATION CONTAINING A BASIC MEDICINAL PRODUCT
AU2003264443A8 (en) Preparation for external use
GB0306081D0 (en) Process for the preparation of a cosmetic active
GB0315617D0 (en) Process for preparing a stable anthelmintic suspension formulation
GB0605431D0 (en) Method of preparing a LiNb1-xTaxO3 film
HU0303383D0 (en) Pellets containing active ingredient